You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 August 2026 - Clinical-stage biotechnology company Graviton BioScience Corporation announced on Wednesday the publication of peer-reviewed data from a multicentre Phase Ib/II multi-dose, open-label clinical trial evaluating the safety, tolerabilit...
27 August 2026 - Cizzle Bio Inc, a biotechnology company advancing biomarker blood tests for early cancer detection, announced on Wednesday its participation in the 18th Annual Next Generation Dx Summit in Washington, D.C.On Monday, Dr. Lary A. Robin...
27 August 2026 - Swiss healthcare company Roche (SIX: RO, ROG; OTCQX: RHHBY) announced on Wednesday that it has received FDA approval for expanded use of its PATHWAY HER2 (4B5) and VENTANA HER2 Dual ISH DNA Probe Cocktail tests.These companion diagno...
26 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Wednesday that the first patient has been dosed in the phase 3 TROPION-Urothelial04 trial evaluating Datroway (datopotamab deruxtecan) as an adjuvant treatment...
26 August 2026 - Japanese stainless steel products manufacturer Nippon Kinzoku Co Ltd (TOKYO:5491) announced on Wednesday that it has begun mass production of ultra-thin, narrow-width stainless steel optimised for laser welding in ultra-fine insulin ...
26 August 2026 - Biotechnology company 4basebio PLC (AIM: 4BB) announced on Wednesday that it has signed a non-exclusive Strategic Collaboration and Marketing Agreement with gene therapy CDMO Genezen to provide drug developers with access to its rese...
26 August 2026 - Inify Laboratories AB (Euronext Growth Oslo:INIFY), a laboratory service that provides diagnostics within pathology, announced on Wednesday that it has launched operations in the UK after completing its laboratory and receiving regul...